Kallyope, Inc. announces Franz Humer as Chair of its board of directors
Kallyope, Inc. announced the appointment of Franz Humer as the new Chair of its board of directors.
Franz Humer, a distinguished global industry leader in the life sciences, finance, and investment, brings decades of managerial experience to the Kallyope board. He served as CEO and Chairman of Roche for over fifteen years, leading the company to become one of the top three global pharmaceutical companies.
Kallyope, Inc. is a biotechnology company that focuses on harnessing the potential of the gut-brain axis to develop innovative therapies.